By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Drugs in Development Information for Sulfatinib
Email this page to a colleague
What is the drug development status for Sulfatinib?
Sulfatinib is an investigational drug.
There have been 14 clinical trials for Sulfatinib.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Neuroendocrine Tumors, Carcinoid Tumor, and Thyroid Neoplasms. The leading clinical trial sponsors are Hutchison Medipharma Limited, BeiGene, and Fudan University.
There are four US patents protecting this investigational drug and twenty-five international patents.
Summary for Sulfatinib
| US Patents | 4 |
| International Patents | 25 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 1 (2015-12-01) |
| Vendors | 29 |
Recent Clinical Trials for Sulfatinib
| Title | Sponsor | Phase |
|---|---|---|
| Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors | BeiGene | Phase 1/Phase 2 |
| Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors | Hutchison Medipharma Limited | Phase 1/Phase 2 |
| Open-Label Surufatinib in European Patients With NET | Hutchison Medipharma Limited | Phase 2 |
Clinical Trial Summary for Sulfatinib
Top disease conditions for Sulfatinib
Top clinical trial sponsors for Sulfatinib
US Patents for Sulfatinib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulfatinib | Try Before You Buy | Stable, concentrated radionuclide complex solutions | ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) | Try Before You Buy |
| Sulfatinib | Try Before You Buy | Stable, concentrated radionuclide complex solutions | ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) | Try Before You Buy |
| Sulfatinib | Try Before You Buy | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | Hutchison MediPharma Limited (Shanghai, CN) | Try Before You Buy |
| Sulfatinib | Try Before You Buy | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | Hutchison Medipharma Limited (Shanghai, CN) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulfatinib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulfatinib | Taiwan | TW202019489 | 2038-07-25 | Try Before You Buy |
| Sulfatinib | World Intellectual Property Organization (WIPO) | WO2020021310 | 2038-07-25 | Try Before You Buy |
| Sulfatinib | World Intellectual Property Organization (WIPO) | WO2020021322 | 2038-07-25 | Try Before You Buy |
| Sulfatinib | World Intellectual Property Organization (WIPO) | WO2020021465 | 2038-07-25 | Try Before You Buy |
| Sulfatinib | World Intellectual Property Organization (WIPO) | WO2020064693 | 2038-07-25 | Try Before You Buy |
| Sulfatinib | Taiwan | TW202019489 | 2038-07-25 | Try Before You Buy |
| Sulfatinib | World Intellectual Property Organization (WIPO) | WO2020021310 | 2038-07-25 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
